Abstract
Objective There remains no standard first-line chemotherapeutic regimen for advanced gastric cancer (AGC). The aim of this study was to evaluate the efficacy and safety of combination regimen with weekly paclitaxel and S-1 as a firstline chemotherapy for AGC.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have